Futura Medical Shares Slump as GlaxoSmithKline (Jobs) Drops Impotence Gel

LONDON, May 14 (Reuters) - Shares in British sexual health specialist Futura Medical Plc lost nearly a third of their value on Monday as GlaxoSmithKline Plc dropped plans to develop its MED2002 anti-impotence gel.

>>> Discuss This Story

Back to news